CLEAR CELL ENDOMETRIAL CARCINOMA
Clinical trials for CLEAR CELL ENDOMETRIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL ENDOMETRIAL CARCINOMA trials appear
Sign up with your email to follow new studies for CLEAR CELL ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to reactivate Cancer-Fighting genes in solid tumors
Disease control Recruiting nowThis phase 2 trial is testing valemetostat, a daily pill, in 900 adults with advanced solid tumors that have specific gene changes (like SMARCB1 or ARID1A). The drug works by blocking EZH1/2 enzymes to reactivate genes that normally protect against cancer. The main goal is to see…
Matched conditions: CLEAR CELL ENDOMETRIAL CARCINOMA
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for Obesity-Linked endometrial cancer: experimental combo enters human trials
Disease control Recruiting nowThis early-stage trial tests the safety of combining two drugs, ONC201 and atezolizumab, in 58 women with advanced or recurrent endometrial cancer. The study includes both obese and non-obese participants to see if body weight affects treatment. The goal is to find the best dose …
Matched conditions: CLEAR CELL ENDOMETRIAL CARCINOMA
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC